PepFinder
recombinant peptideCardiovascular Peptides

Nesiritide

Recombinant human BNP. Was FDA-approved (2001) for acute decompensated heart failure but fell out of use after the ASCEND-HF trial failed to show clinical outcome benefit. Provides vasodilation and diuresis.

heart-failurevasodilationdiureticFDA-approved
3D Structure
3D Structure
3464.01 Da
Molecular Weight3,464.01 Da
FormulaC143H244N50O42S4
PubChem CID71308561
Lab Tested
No
Harmful Ingredients
0
Contaminants
None
Tested Purity
--
Batch Consistency
No batch data
Mass Spec Profile
Intensity17322171260930473486m/z3463.8
ESI-MS (computed)
Batch Info
Latest Batch—
Total Tests0
Unique Vendors0
Vendor Comparison
No vendor data yet
Analysis Summary
Purity Standard
No purity data
Lab Reports
0 reports on file
Summary

Recombinant human BNP. Was FDA-approved (2001) for acute decompensated heart failure but fell out of use after the ASCEND-HF trial failed to show clinical outcome benefit. Provides vasodilation and di…